Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 26Uterine Cervical Neoplasms 16Endometrial Neoplasms 14Fallopian Tube Neoplasms 10Carcinoma, Ovarian Epithelial 7Colorectal Neoplasms 6Peritoneal Neoplasms 5Neoplasms 5Uterine Cervical Dysplasia 4Lung Neoplasms 4Gestational Trophoblastic Disease 4Pancreatic Neoplasms 3Neoplasms by Site 3Neoplasms by Histologic Type 3Melanoma 3Hematologic Neoplasms 3Endometrial Hyperplasia 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Prostatic Neoplasms 2Progesterone Resistance 2Ovarian Cysts 2Obesity 2Multiple Myeloma 2Lymphoproliferative Disorders 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Glioma 2

Interventions

Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Drug-Related Side Effects and Adverse Reactions × Gynecologic × Clear all
NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6

Women's Hospital School Of Medicine Zhejiang University

Phase 2/3 Unknown
300 enrolled
Gynecologic

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡